🔴 Immunic is trading 16.59% down in pre-market

Immunic is trading 16.59% lower at $9.04 in pre-market, with no clear company-specific catalyst identified for September 23, 2026.

• The investor-relations page lists September 2 as the latest press release; available coverage centers on earlier R&D Day and management updates.
• The decline runs counter to broader biotechnology strength, with XBI up 2.61% pre-market.
• The catalyst remains unclear and may reflect delayed or undisclosed trading-specific news.